End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.27 CNY | +0.54% | +1.53% | -16.11% |
May. 14 | Zhejiang Jianfeng's Pharmaceutical Unit Gets Nod to Market Anti-Tumor Drug | MT |
May. 07 | Jianfeng Group's Pharma Unit Gets Nod to Sell Glaucoma Eye Drops | MT |
Sales 2022 | 3.56B 492M | Sales 2023 | 2.89B 400M | Capitalization | 3.8B 526M |
---|---|---|---|---|---|
Net income 2022 | 288M 39.84M | Net income 2023 | 93M 12.86M | EV / Sales 2022 | 1.26 x |
Net Debt 2022 | 109M 15.09M | Net Debt 2023 | 341M 47.18M | EV / Sales 2023 | 1.43 x |
P/E ratio 2022 |
15.2
x | P/E ratio 2023 |
40.6
x | Employees | 2,104 |
Yield 2022 |
1.18% | Yield 2023 |
-
| Free-Float | 76.01% |
1 day | +0.54% | ||
1 week | +1.53% | ||
Current month | +5.34% | ||
1 month | +6.92% | ||
3 months | +1.76% | ||
6 months | -18.47% | ||
Current year | -16.11% |
Managers | Title | Age | Since |
---|---|---|---|
Jian Hong Yu
CEO | Chief Executive Officer | 58 | 08-09-04 |
Xiao Long Lan
DFI | Director of Finance/CFO | 51 | 14-11-11 |
Jin Long Huang
BRD | Director/Board Member | 59 | 08-09-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Su Jian Huang
BRD | Director/Board Member | 69 | 17-05-18 |
Xiao Meng Jiang
CHM | Chairman | 60 | 07-08-16 |
Qi Fu
BRD | Director/Board Member | 45 | 20-11-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 9.27 | +0.54% | 3,004,601 |
24-05-16 | 9.22 | +1.32% | 3,558,559 |
24-05-15 | 9.1 | -0.33% | 1,653,988 |
24-05-14 | 9.13 | +0.88% | 2,101,380 |
24-05-13 | 9.05 | -0.88% | 2,242,388 |
End-of-day quote Shanghai S.E., May 16, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-16.11% | 442M | |
+18.87% | 48.58B | |
+18.63% | 17.59B | |
-3.19% | 15.9B | |
-8.25% | 11.39B | |
+26.36% | 8.83B | |
+45.17% | 8.05B | |
-1.05% | 7.93B | |
-2.73% | 7.93B | |
+105.28% | 7.5B |
- Stock Market
- Equities
- 600668 Stock